DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines - PubMed (original) (raw)

Comparative Study

DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines

H L Davis et al. Proc Natl Acad Sci U S A. 1996.

Abstract

Vaccination of two chimpanzees against hepatitis B virus (HBV) by intramuscular injection of plasmid DNA encoding the major and middle HBV envelope proteins induced group-, subtype- and preS2-specific antibodies. These were initially of IgM isotype, and then they were of IgG (predominantly IgGl) isotype. The chimpanzee injected with 2 mg of DNA attained >100 milli-international units/ml of anti-HBs antibody after one injection and 14,000 milli-international units/ml after four injections. A smaller dose (400 microg) induced lower and transient titers, but a strong anamnestic response occurred 1 year later. Comparison with responses in 23 chimpanzees receiving various antigen-based HBV vaccines suggests that the DNA approach is promising for prophylactic immunization against HBV.

PubMed Disclaimer

Similar articles

• DNA-based immunization against the envelope proteins of the hepatitis B virus.
  Mancini M, Davis H, Tiollais P, Michel ML. Mancini M, et al. J Biotechnol. 1996 Jan 26;44(1-3):47-57. doi: 10.1016/0168-1656(95)00098-4. J Biotechnol. 1996. PMID: 8717386
• Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
  Payette PJ, Ma X, Weeratna RD, McCluskie MJ, Shapiro M, Engle RE, Davis HL, Purcell RH. Payette PJ, et al. Intervirology. 2006;49(3):144-51. doi: 10.1159/000089375. Intervirology. 2006. PMID: 16428890
• Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
  Kim SH, Shin YW, Hong KW, Chang KH, Ryoo KH, Paik SH, Kim JM, Brotman B, Pfahler W, Prince AM. Kim SH, et al. Antiviral Res. 2008 Sep;79(3):188-91. doi: 10.1016/j.antiviral.2008.03.006. Epub 2008 Apr 28. Antiviral Res. 2008. PMID: 18479762
• Interactions of hepatitis B virus with hepatocytes: mechanism and clinical relevance.
  Theilmann L, Goeser T. Theilmann L, et al. Hepatogastroenterology. 1991 Feb;38(1):10-3. Hepatogastroenterology. 1991. PMID: 1709133 Review.
• The immune response to hepatitis B virus.
  Waters JA, Pignatelli M, Brown D, O'Rourke S, Lever A, Thomas HC. Waters JA, et al. Postgrad Med J. 1987;63 Suppl 2:51-6. Postgrad Med J. 1987. PMID: 2446303 Review.

Cited by

• Novel mechanism of gene transfection by low-energy shock wave.
  Ha CH, Lee SC, Kim S, Chung J, Bae H, Kwon K. Ha CH, et al. Sci Rep. 2015 Aug 5;5:12843. doi: 10.1038/srep12843. Sci Rep. 2015. PMID: 26243452 Free PMC article.
• Induced immunity against hepatitis B virus.
  Said ZN, Abdelwahab KS. Said ZN, et al. World J Hepatol. 2015 Jun 28;7(12):1660-70. doi: 10.4254/wjh.v7.i12.1660. World J Hepatol. 2015. PMID: 26140085 Free PMC article. Review.
• The chimpanzee model for hepatitis B virus infection.
  Wieland SF. Wieland SF. Cold Spring Harb Perspect Med. 2015 Jun 1;5(6):a021469. doi: 10.1101/cshperspect.a021469. Cold Spring Harb Perspect Med. 2015. PMID: 26033082 Free PMC article. Review.
• Cationic lipid-formulated DNA vaccine against hepatitis B virus: immunogenicity of MIDGE-Th1 vectors encoding small and large surface antigen in comparison to a licensed protein vaccine.
  Endmann A, Klünder K, Kapp K, Riede O, Oswald D, Talman EG, Schroff M, Kleuss C, Ruiters MH, Juhls C. Endmann A, et al. PLoS One. 2014 Jul 3;9(7):e101715. doi: 10.1371/journal.pone.0101715. eCollection 2014. PLoS One. 2014. PMID: 24992038 Free PMC article.
• Cimetidine synergizes with Praziquantel to enhance the immune response of HBV DNA vaccine via activating cytotoxic CD8(+) T cell.
  Xie X, Geng S, Liu H, Li C, Yang Y, Wang B. Xie X, et al. Hum Vaccin Immunother. 2014;10(6):1688-99. doi: 10.4161/hv.28517. Epub 2014 Mar 18. Hum Vaccin Immunother. 2014. PMID: 24643207 Free PMC article.

References

1. 1. Hum Gene Ther. 1992 Feb;3(1):21-33 - PubMed
2. 1. EMBO J. 1984 Mar;3(3):645-50 - PubMed
3. 1. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7708-12 - PubMed
4. 1. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9519-23 - PubMed
5. 1. Clin Microbiol Rev. 1995 Jul;8(3):406-10 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information